Byoungsan Choi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Byoungsan Choi has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
Dae Hee Lee
Proteina Co. Ltd., Seoul, Republic of Korea
1 shared publicationGee Sung Eun
School of Biological Sciences and Institute for Molecular Biology and Genetics, Seoul National University, Seoul, Republic of Korea
1 shared publication- Minkwon Cha
Department of Physics, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, Republic of Korea
1 shared publication Muhammad Ehsan
Department of Bionanotechnology, Hanyang University, Ansan, Republic of Korea
1 shared publicationPil Seok Chae
Department of Bionanotechnology, Hanyang University, Ansan, Republic of Korea
1 shared publicationSeul Lee
Proteina Co. Ltd., Seoul, Republic of Korea
1 shared publication
Latest Publications
- Open Access
- 8 April 2020
- Published by eLife Sciences Publications, Ltd in eLife
- Vol. 9
Single-molecule functional anatomy of endogenous HER2-HER3 heterodimers
Human epidermal growth factor receptors (HERs) are the primary targets of many directed cancer therapies. However, the reason a specific dimer of HERs generates a stronger proliferative signal than other permutations remains unclear. Here, we used single-molecule immunoprecipitation to develop a biochemical assay for endogenously-formed, entire HER2-HER3 heterodimers. We observed unexpected, large conformational fluctuations in juxta-membrane and kinase domains of the HER2-HER3 heterodimer. Nevertheless, the individual HER2-HER3 heterodimers catalyze tyrosine phosphorylation at an unusually high rate, while simultaneously interacting with multiple copies of downstream signaling effectors. Our results suggest that the high catalytic rate and multi-tasking capability make a concerted contribution to the strong signaling potency of the HER2-HER3 heterodimers.
- 8 April 2020
- Published by eLife Sciences Publications, Ltd in eLife
- Vol. 9
Open AccessSingle-molecule functional anatomy of endogenous HER2-HER3 heterodimers
Human epidermal growth factor receptors (HERs) are the primary targets of many directed cancer therapies. However, the reason a specific dimer of HERs generates a stronger proliferative signal than other permutations remains unclear. Here, we used single-molecule immunoprecipitation to develop a biochemical assay for endogenously-formed, entire HER2-HER3 heterodimers. We observed unexpected, large conformational fluctuations in juxta-membrane and kinase domains of the HER2-HER3 heterodimer. Nevertheless, the individual HER2-HER3 heterodimers catalyze tyrosine phosphorylation at an unusually high rate, while simultaneously interacting with multiple copies of downstream signaling effectors. Our results suggest that the high catalytic rate and multi-tasking capability make a concerted contribution to the strong signaling potency of the HER2-HER3 heterodimers.